DK0714386T3 - Vandopløseligt nimesulidsalt og anvendelse deraf til behandling af inflammatoriske lidelser - Google Patents
Vandopløseligt nimesulidsalt og anvendelse deraf til behandling af inflammatoriske lidelserInfo
- Publication number
- DK0714386T3 DK0714386T3 DK95922359T DK95922359T DK0714386T3 DK 0714386 T3 DK0714386 T3 DK 0714386T3 DK 95922359 T DK95922359 T DK 95922359T DK 95922359 T DK95922359 T DK 95922359T DK 0714386 T3 DK0714386 T3 DK 0714386T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- water
- pct
- inflammatory disorders
- soluble
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Detergent Compositions (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9400582A BE1008307A3 (fr) | 1994-06-16 | 1994-06-16 | Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation. |
PCT/BE1995/000055 WO1995034533A1 (fr) | 1994-06-16 | 1995-06-16 | Sel de nimesulide hydrosoluble et leurs utilisations pour le traitement des affections inflammatoires |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0714386T3 true DK0714386T3 (da) | 1999-09-27 |
Family
ID=3888206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95922359T DK0714386T3 (da) | 1994-06-16 | 1995-06-16 | Vandopløseligt nimesulidsalt og anvendelse deraf til behandling af inflammatoriske lidelser |
Country Status (19)
Country | Link |
---|---|
US (1) | US5756546A (da) |
EP (1) | EP0714386B1 (da) |
JP (1) | JPH09503002A (da) |
AT (1) | ATE177421T1 (da) |
AU (1) | AU693901B2 (da) |
BE (1) | BE1008307A3 (da) |
CA (1) | CA2169747A1 (da) |
CZ (1) | CZ289746B6 (da) |
DE (1) | DE69508192T2 (da) |
DK (1) | DK0714386T3 (da) |
ES (1) | ES2132678T3 (da) |
GR (1) | GR3030437T3 (da) |
HU (1) | HUT76475A (da) |
NZ (1) | NZ288150A (da) |
PL (1) | PL179789B1 (da) |
RU (1) | RU2151764C1 (da) |
SK (1) | SK281496B6 (da) |
UA (1) | UA42734C2 (da) |
WO (1) | WO1995034533A1 (da) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997012608A1 (fr) * | 1995-10-05 | 1997-04-10 | Helsinn Healthcare S.A. | Agent anti-inflammatoire externe |
HUP9601442A3 (en) * | 1995-07-25 | 1999-03-29 | Panacea Biotec Ltd | Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them |
NO965193L (no) | 1995-12-08 | 1997-06-09 | Seikagaku Kogyo Kk Seikagaku C | Aminalkoholderivat og fremgangsmåte for fremstilling derav |
UA57734C2 (uk) | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
IN186315B (da) * | 1996-12-12 | 2001-08-04 | Panacea Biotec Ltd | |
ES2129010B1 (es) * | 1997-01-02 | 2000-01-16 | Gold Oscar | Composicion de accion prolongada en granulos que contienen 4-nitro-2- fenoximetansulfonanilida y su procedimiento de preparacion. |
IT1290448B1 (it) * | 1997-04-01 | 1998-12-03 | Schiena Michele Giuseppe Di | Nimesulide sale di colina,metodo di preparazione e composizioni farmaceutiche che lo contengono |
AU718356B2 (en) * | 1998-01-12 | 2000-04-13 | Panacea Biotec Limited | A parenteral water-miscible non-intensely coloured injectable composition of non-steroidal anit-inflammatory drugs |
AU1885999A (en) * | 1998-02-17 | 1999-08-30 | Miciopharma Chemical Aktiengesellschaft | A watersoluble nimesulide adduct also for injectable use |
US8236352B2 (en) * | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
US20040013613A1 (en) * | 2001-05-18 | 2004-01-22 | Jain Rajeev A | Rapidly disintegrating solid oral dosage form |
US20080213378A1 (en) * | 1998-10-01 | 2008-09-04 | Elan Pharma International, Ltd. | Nanoparticulate statin formulations and novel statin combinations |
WO2000018374A1 (en) * | 1998-10-01 | 2000-04-06 | Elan Pharma International, Ltd. | Controlled release nanoparticulate compositions |
US20040141925A1 (en) * | 1998-11-12 | 2004-07-22 | Elan Pharma International Ltd. | Novel triamcinolone compositions |
US6969529B2 (en) * | 2000-09-21 | 2005-11-29 | Elan Pharma International Ltd. | Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
US6428814B1 (en) * | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
US20040115134A1 (en) * | 1999-06-22 | 2004-06-17 | Elan Pharma International Ltd. | Novel nifedipine compositions |
US20040156872A1 (en) * | 2000-05-18 | 2004-08-12 | Elan Pharma International Ltd. | Novel nimesulide compositions |
PE20020300A1 (es) * | 2000-08-22 | 2002-05-10 | Pharmacia Corp | Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco |
US7198795B2 (en) | 2000-09-21 | 2007-04-03 | Elan Pharma International Ltd. | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions |
PE20021017A1 (es) * | 2001-04-03 | 2002-11-24 | Pharmacia Corp | Composicion parenteral reconstituible |
BR0102252B1 (pt) * | 2001-04-10 | 2013-10-22 | Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso | |
ATE464880T1 (de) | 2002-02-04 | 2010-05-15 | Elan Pharma Int Ltd | Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator |
US20040101566A1 (en) * | 2002-02-04 | 2004-05-27 | Elan Pharma International Limited | Novel benzoyl peroxide compositions |
AR038576A1 (es) * | 2002-02-22 | 2005-01-19 | Pharmacia Corp | Formulaciones de drogas antibioticas oftalmicas que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio |
EP1487540A2 (en) * | 2002-03-20 | 2004-12-22 | Pharmacia Corporation | Storage stable eplerenone formulation |
EP2283864A1 (en) * | 2002-07-16 | 2011-02-16 | Elan Pharma International Ltd. | Liquid dosage compositions fo stable nanoparticulate active agents |
CN1511828A (zh) * | 2002-12-31 | 2004-07-14 | �й������ž�����ҽѧ��ѧԺ����ҽ | 磺酰苯胺类衍生物及其医药用途 |
ITMI20041121A1 (it) * | 2004-06-03 | 2004-09-03 | Advance Holdings Ltd | Derivato della nimesulide metodo per prepararlo e composizione farmaceutica che lo comprende |
US7576222B2 (en) * | 2004-12-28 | 2009-08-18 | Wyeth | Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase |
EP1902705A1 (en) * | 2006-09-22 | 2008-03-26 | Pharmatex Italia Srl | Injectable pharmaceutical nimesulide solutions |
BE1018279A3 (fr) * | 2008-09-09 | 2010-08-03 | Squarepoint Pointcarre Sprl | Composition de nimesulide orodispersible. |
BE1018280A3 (fr) * | 2008-09-09 | 2010-08-03 | Squarepoint Pointcarre Sprl | Composition de nimesulide a liberation prolongee. |
US20120171184A1 (en) | 2010-12-31 | 2012-07-05 | Lajos Szente | Cellular hydration compositions |
JP2015044850A (ja) * | 2014-11-07 | 2015-03-12 | イーストポンド・ラボラトリーズ・リミテッド | シクロデキストリンを含有する細胞水和組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3840597A (en) * | 1971-02-24 | 1974-10-08 | Riker Laboratories Inc | Substituted 2-phenoxy alkane-sulfonanilides |
AR206496A1 (es) * | 1972-07-03 | 1976-07-30 | Riker Laboratories Inc | Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas |
US4983628A (en) * | 1983-10-27 | 1991-01-08 | Merck Frosst Canada, Inc. | Leukotriene antagonists |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
IT1248475B (it) * | 1990-05-22 | 1995-01-19 | Angeli Inst Spa | Composti di inclusione di nimesulide con ciclodestrine |
-
1994
- 1994-06-16 BE BE9400582A patent/BE1008307A3/fr not_active IP Right Cessation
-
1995
- 1995-06-16 UA UA96031021A patent/UA42734C2/uk unknown
- 1995-06-16 EP EP95922359A patent/EP0714386B1/fr not_active Expired - Lifetime
- 1995-06-16 CA CA002169747A patent/CA2169747A1/fr not_active Abandoned
- 1995-06-16 DE DE69508192T patent/DE69508192T2/de not_active Expired - Fee Related
- 1995-06-16 US US08/596,348 patent/US5756546A/en not_active Expired - Fee Related
- 1995-06-16 RU RU96105706/04A patent/RU2151764C1/ru active
- 1995-06-16 NZ NZ288150A patent/NZ288150A/en unknown
- 1995-06-16 SK SK356-96A patent/SK281496B6/sk unknown
- 1995-06-16 DK DK95922359T patent/DK0714386T3/da active
- 1995-06-16 WO PCT/BE1995/000055 patent/WO1995034533A1/fr active IP Right Grant
- 1995-06-16 AU AU27085/95A patent/AU693901B2/en not_active Ceased
- 1995-06-16 AT AT95922359T patent/ATE177421T1/de not_active IP Right Cessation
- 1995-06-16 CZ CZ1996792A patent/CZ289746B6/cs not_active IP Right Cessation
- 1995-06-16 JP JP8501408A patent/JPH09503002A/ja active Pending
- 1995-06-16 ES ES95922359T patent/ES2132678T3/es not_active Expired - Lifetime
- 1995-06-16 PL PL95313031A patent/PL179789B1/pl unknown
- 1995-06-16 HU HU9600654A patent/HUT76475A/hu unknown
-
1999
- 1999-06-09 GR GR990401524T patent/GR3030437T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HUT76475A (en) | 1997-09-29 |
AU693901B2 (en) | 1998-07-09 |
US5756546A (en) | 1998-05-26 |
DE69508192T2 (de) | 1999-10-14 |
RU2151764C1 (ru) | 2000-06-27 |
AU2708595A (en) | 1996-01-05 |
SK281496B6 (sk) | 2001-04-09 |
PL313031A1 (en) | 1996-05-27 |
GR3030437T3 (en) | 1999-09-30 |
BE1008307A3 (fr) | 1996-04-02 |
UA42734C2 (uk) | 2001-11-15 |
SK35696A3 (en) | 1996-12-04 |
CA2169747A1 (fr) | 1995-12-21 |
NZ288150A (en) | 1998-09-24 |
ATE177421T1 (de) | 1999-03-15 |
MX9600642A (es) | 1997-07-31 |
CZ289746B6 (cs) | 2002-03-13 |
HU9600654D0 (en) | 1996-05-28 |
PL179789B1 (pl) | 2000-10-31 |
EP0714386A1 (fr) | 1996-06-05 |
DE69508192D1 (de) | 1999-04-15 |
CZ79296A3 (en) | 1996-10-16 |
ES2132678T3 (es) | 1999-08-16 |
JPH09503002A (ja) | 1997-03-25 |
EP0714386B1 (fr) | 1999-03-10 |
WO1995034533A1 (fr) | 1995-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0714386T3 (da) | Vandopløseligt nimesulidsalt og anvendelse deraf til behandling af inflammatoriske lidelser | |
SE0100901D0 (sv) | New composition | |
NO20061736L (no) | Krystallform av epotilon B | |
DE69634045D1 (de) | Antithrombotische diamine | |
SE9802729D0 (sv) | Novel Compounds | |
FR2754820B1 (fr) | Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant | |
ATE262895T1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
BRPI0414215A (pt) | tienopirazóis | |
PT815087E (pt) | Derivados de fenilo trissubstituidos | |
MY107573A (en) | 2,4- and 2, 5-substituted pyridine-n-oxides, processes for their preparation and their use. | |
TR200002248T2 (tr) | Yeni dihidroksiheksanoik asit türevleri | |
DE60228878D1 (de) | Proteine mit il-6 inhibitorischer wirkung | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
BG101126A (en) | The use of muramylpeptide compounds | |
DK0787135T3 (da) | Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh | |
TNSN96016A1 (fr) | Utilisation de phenylcyclohexylcarboxamides | |
ITMI920955A1 (it) | Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili | |
AU3862997A (en) | Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof | |
DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
ES2128426T3 (es) | Retinoides acuosolubles. | |
DE69905489D1 (de) | Protein c zur behandlung von sichelzellanämie und thalassämie | |
DE60003074D1 (de) | Fusidinsäure-derivate | |
DE3777359D1 (de) | Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns. | |
TR200101476T2 (tr) | N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması | |
PT971714E (pt) | Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia |